Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

U Hamid (1) , A Krasnodembskaya , M Fitzgerald , M Shyamsundar , A Kissenpfennig , C Scott , E Lefrancais (2) , M Looney , R Verghis , J Scott , A Simpson , J Mcnamee , D Mcauley , C O'Kane

1 QUB - Queen's University [Belfast]
2 UCSF - Department of Medicine, Microbiology and Immunology

Domains: Life Sciences [q-bio]; Life Sciences [q-bio]; Human health and pathology; Pulmonology and respiratory tract; Life Sciences [q-bio]; Immunology; Innate immunity; Life Sciences [q-bio]; Biochemistry, Molecular Biology; Life Sciences [q-bio]; Human health and pathology; Tissues and Organs [q-bio.TO]

U Hamid, A Krasnodembskaya, M Fitzgerald, M Shyamsundar, A Kissenpfennig, et al.. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. Thorax, 2017, 72 (11), pp.971-980. ⟨10.1136/thoraxjnl-2016-208571⟩. ⟨hal-02997990⟩